Cargando…
Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A
A hallmark of Fanconi anemia is accelerated decline in hematopoietic stem and progenitor cells (CD34 +) leading to bone marrow failure. Long-term treatment requires hematopoietic cell transplantation from an unaffected donor but is associated with potentially severe side-effects. Gene therapy to cor...
Autores principales: | Adair, Jennifer E., Chandrasekaran, Devikha, Sghia-Hughes, Gabriella, Haworth, Kevin G., Woolfrey, Ann E., Burroughs, Lauri M., Choi, Grace Y., Becker, Pamela S., Kiem, Hans-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278989/ https://www.ncbi.nlm.nih.gov/pubmed/29976742 http://dx.doi.org/10.3324/haematol.2018.194571 |
Ejemplares similares
-
Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia
por: Thakar, Monica S., et al.
Publicado: (2017) -
Effective Multi-lineage Engraftment in a Mouse Model of Fanconi Anemia Using Non-genotoxic Antibody-Based Conditioning
por: Srikanthan, Meera A., et al.
Publicado: (2020) -
Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector
por: Becker, Pamela S., et al.
Publicado: (2010) -
Identification of the Fanconi Anemia Complementation Group I Gene, FANCI
por: Dorsman, Josephine C., et al.
Publicado: (2007) -
Fanconi Anemia complementation group C protein in metabolic disorders
por: Nepal, Manoj, et al.
Publicado: (2018)